Company Directory

Tarsa Therapeutics developed TBRIA™, an oral formulation of calcitonin for postmenopausal osteoporosis. Rights to TBRIA have been acquired by R-Pharm JSC, whose US subsidiary is responsible for the continuing clinical development of TBRIA and subsequent regulatory submissions.

Team Consulting is a fee-for-service consultancy that works with pharma and medtech clients to design and develop medical devices, in particular drug delivery devices. In the field of drug delivery, Team Consulting's focus is in administation via the respiratory and parenteral routes.

teamtechnik specialises in highly automated assembly and testing systems in the fields of medical technology, new energy and e-mobility. Medical devices are a strong focus, in particular production systems for autoinjectors, injection pens, glass syringes and safety devices.

Technolution is a product development consultancy that works with pharma and medtech companies at all stages of development from initial concept through to the finalised product. Products it specialises in include medical devices, combination products and connected devices (IoT).

ten23 health is a CDMO that supports its clients in developing differentiated, stable, usable and safe injectables, and has specialist experience in the sterile filling of complex pharmaceuticals into innovative containers and devices.

TerraCycle develops innovative sustainability solutions, internationally creating and operating first-of-their-kind platforms in recycling, recycled materials and reuse, including industry-first recycling solutions for medicine blister packs, syringe filters and inhalers.

Terumo Pharmaceutical Solutions is a division of Terumo focused on designing and developing drug delivery devices. The company's product line includes pre-fillable syringe systems, hypodermic needles, catheters, infusion sets and safety devices for infusion sets and needles.

Tillotts Pharma is a gastroenterology-focused specialty pharmaceutical company, which markets its own products and offers technologies for intestinal targeted drug delivery: OPTICORE™ for colonic targeting, and ECX™, which targets the ileum and the ascending and transverse colon.

TISSIUM is developing and commercialising a synthetic polymer platform, based on a proprietary polymer family with properties including the ability to conform to, and integrate with, surrounding tissue. The technology has several applications in drug delivery.